- Location
Amgen
"-
Swiftwick Is Proud to Be The Official Sock of The 2014 5-Hour Energy Presented
Feb 19, 2014Swiftwick, a leading U.S. producer of athletic compression socks, is proud to be the official sock of the 2014 5-hour ENERGY presented by Kenda Racing Team. Last season the team chalked up more than 30 podium finishes after racing in three ...
Tags: Energy Cycling Team, Apparel
-
Developing Oncology Companion Diagnostic Test Was Agreed by Amgen and Illumina
Jan 17, 2014Illumina has entered into an agreement with Amgen to develop and commercialize a multigene, NGS-based test as a companion diagnostic for Vectibix (panitumumab), a fully human anti-EGFR monoclonal antibody therapeutic for the treatment of ...
Tags: Amgen, FDA, CE, Illumina Oncology
-
Romosozumab Is an Investigational Medicine in Phase 3 Clinical Development
Jan 3, 2014Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels:UCB) today announced results from a Phase 2 trial evaluating romosozumab (AMG 785/CDP7851) in postmenopausal women with low bone mineral density (BMD). Published in the New England Journal of ...
Tags: Amgen, UCB, Phase 2 trial evaluating romosozumab, postmenopausal women
-
Monoclonal Antibody Agents Have Been Successfully Used in The Treatment of Tumors
Dec 23, 2013Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the market size of monoclonal antibody agents ...
-
BIND Therapeutics Amended Its Development and Commercialization Collaboration Agreement
Dec 16, 2013BIND Therapeutics, a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, has amended its development and commercialization collaboration agreement with Amgen to extend the period ...
-
Sutro Biopharma Has Received $26m in a Series D Financing
Dec 13, 2013Sutro Biopharma has received $26m in a Series D financing, which will be used for the expansion of its proprietary immuno-oncology product pipeline. The company is currently using its cell-free protein synthesis technology to develop new ...
-
The 2014 Edition of The USA Pro Challenge Stage Race Will Feature a Mountain Top Finish
Nov 5, 2013The 2014 edition of the USA Pro Challenge stage race will feature a mountain top finish on Monarch Mountain, a ski resort west of Salida, Colo., in the center of the state. On Monday the organizers of the race — considered the ...
Tags: Transportation, bike
-
Amgen in Terms of Market Cap Declared The Establishment of a Chinese R&D Center
Sep 27, 2013World biggest biopharmaceutical company Amgen in terms of market cap declared the establishment of a Chinese R&D center, another important step taken after forming a JV with Zhejiang Beta Pharma in May 2013. Amgen Global Business ...
Tags: Health, Medicine, generic drugs
-
Purchase Price of The Transaction Expected to Be Closed by The Beginning Is $10.4bn
Aug 27, 2013Biotechnology company Amgen has reached a deal to buy all outstanding shares of California-based Onyx Pharmaceuticals for $125 per share in cash. The purchase price of the transaction that is expected to be closed by the beginning of ...
Tags: Amgen, Onyx Pharmaceuticals
-
Medtronic's Interventional Spine Division Has Signed a Three-Year Agreement
Jul 18, 2013Medtronic's Interventional Spine division has signed a three-year agreement to promote Amgen's Prolia (denosumab) to orthopedic and spine specialists in the US. Prolia is approved in the US to treat postmenopausal women with osteoporosis ...
-
Cannondale Launches The Second Issue of The Cannondale Gazette of The Tour De France
Jun 27, 2013Cannondale has launched the second issue of the Cannondale Gazette for the 100th anniversary of the Tour de France. The free digital magazine is created by Cannondale in partnership with Peloton magazine.? The Cannondale Gazette includes ...
Tags: Transportation, bike
-
US FDA Gave Its Clearance to Amgen's XGEVA to Treat Adult or Skeletally Mature Patients
Jun 14, 2013The US Food and Drug Administration (FDA) has given its clearance to Amgen's XGEVA (denosumab) to treat adult or skeletally mature patients suffering from giant cell tumor of bone (GCTB). Approved after conducting a priority review, XGEVA ...
Tags: Amgen's XGEVA, Medicine
-
Daiichi Sankyo Company Has Launched Pralia Subcutaneous Injection 60mg Syringe
Jun 13, 2013Daiichi Sankyo Company has launched Pralia subcutaneous injection 60mg syringe (generic name denosumab) for the treatment of osteoporosis, following its manufacturing and marketing approval in Japan. Designed to specifically inhibit an ...
Tags: Daiichi Sankyo, Syringe
-
Osmo Nutrition Announced Its Sponsorship of The Cannondale PRO Cycling Team
May 21, 2013FAIRFAX, CA (BRAIN) — Osmo Nutrition announced its sponsorship of the Cannondale Pro Cycling team two stages into this year's Amgen Tour of California, which ended Sunday. The California nutritional company began supplying the team ...
Tags: Transportation, FAIRFAX, Cannondale Team
-
Clothing Maker Champion System to Celebrate Shipping Its 5 Millionth Jersey
Apr 23, 2013Clothing maker Champion System is taking a page from Willy Wonka's marketing book to celebrate shipping its 5 millionth jersey. The company is including a gold colored mini-jersey with one order chosen at random. The customer who finds ...
Tags: bike, Apparel, Transportation, race Apparel